Platinum complex compound and utilization of the same
AssigneesKabushiki Kaisha Yakult Honsha, Tenshindo Pharmaceutical Co., Ltd.
InventorsSeiji Komeda, Masahiko Chikuma
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel dinuclear platinum(II) complex compound that can bind to DNA by a mode different from that of cisplatin-type drugs, a method of producing this compound and an anticancer agent comprising this compound as an effective component. This compound is a tetrazolato-bridged platinum complex compound represented by the following formula (I), wherein A is optionally substituted tetrazolato, B is an inorganic or organic anion, and m and n are integers determined in accordance with the charge number of the platinum complex ion and the charge number of the anion.
Claims8
A platinum complex compound represented by the following formula (I)
- [C1]
- (in the formula, A is tetrazolato that has or does not have a substituent group, B is an organic or inorganic anion, and m and n are integers determined in accordance with the charge number of the platinum complex moiety and the charge number of B).
Dependencies are inferred from the claim text.